Section Arrow
PROF.NASDAQ
- Profound Medical Corp
Quotes are at least 15-min delayed:2025/01/21 05:40 EST
Last
 7.35
-0.08 (-1.08%)
Day High 
7.55 
Prev. Close
7.43 
1-M High
7.99 
Volume 
57.67K 
Bid
5.99
Ask
9.73
Day Low
7.22 
Open
7.5 
1-M Low
6.78 
Market Cap 
223.11M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.6 
20-SMA 7.38 
50-SMA 7.71 
52-W High 11.42 
52-W Low 6.78 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.34/-0.94
Enterprise Value
228.69M
Balance Sheet
Book Value Per Share
1.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.20M
Operating Revenue Per Share
0.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:40 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.